Key facts
- This page summarizes James E. Dentzer's Form 4 filing for Imunon, Inc. (IMNN).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 27 May 2026, 16:13.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
Stock granted in lieu of cash for portion of board fees
SEC remarks
On August 21, 2025, the Issuer paid a 15% stock dividend, 0.15 shares of common stock per share of the Issuer's issued and outstanding shares of common stock, to stockholders of record as of August 7, 2025. As a result of the stock dividend, the shares of Issuer Common Stock have been adjusted accordingly versus any amounts previously reported by the Reporting Person.